FR2358398A1 - Medicament a base du sel cereux de la sulfadiazine - Google Patents

Medicament a base du sel cereux de la sulfadiazine

Info

Publication number
FR2358398A1
FR2358398A1 FR7721651A FR7721651A FR2358398A1 FR 2358398 A1 FR2358398 A1 FR 2358398A1 FR 7721651 A FR7721651 A FR 7721651A FR 7721651 A FR7721651 A FR 7721651A FR 2358398 A1 FR2358398 A1 FR 2358398A1
Authority
FR
France
Prior art keywords
sulfadiazine
cerous
product based
medicinal product
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7721651A
Other languages
English (en)
Other versions
FR2358398B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of FR2358398A1 publication Critical patent/FR2358398A1/fr
Application granted granted Critical
Publication of FR2358398B1 publication Critical patent/FR2358398B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69—Benzenesulfonamido-pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention a pour objet un médicament utilisable pour le traitement des brûlures. Ce médicament comprend comme matière active un sel de cérium de la sulfadiazine, plus particulièrement la sulfadiazine céreuse, qui peut être associée à d'autres agents antibactériens comme la sulfadiazine zincique ou la sulfadiazine argentique, ainsi qu'avec de l'acide para-aminobenzoïque. La sulfadiazine céreuse est préparée par réaction d'une solution aqueuse de sulfadiazine sodique avec une solution aqueuse d'un sel céreux tel que le nitrate ou le chlorure.
FR7721651A 1976-07-13 1977-07-13 Medicament a base du sel cereux de la sulfadiazine Granted FR2358398A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/704,817 US4078058A (en) 1976-07-13 1976-07-13 Cerium sulfadiazine for treating burns

Publications (2)

Publication Number Publication Date
FR2358398A1 true FR2358398A1 (fr) 1978-02-10
FR2358398B1 FR2358398B1 (fr) 1980-07-04

Family

ID=24830983

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7721651A Granted FR2358398A1 (fr) 1976-07-13 1977-07-13 Medicament a base du sel cereux de la sulfadiazine

Country Status (15)

Country Link
US (1) US4078058A (fr)
JP (1) JPS5338615A (fr)
AU (1) AU512668B2 (fr)
BE (1) BE856751A (fr)
CA (1) CA1071204A (fr)
DE (1) DE2731648A1 (fr)
ES (1) ES460664A1 (fr)
FR (1) FR2358398A1 (fr)
GB (1) GB1553322A (fr)
IL (1) IL52483A0 (fr)
IN (1) IN146083B (fr)
LU (1) LU77752A1 (fr)
NL (1) NL7707555A (fr)
SE (1) SE7708123L (fr)
ZA (1) ZA774175B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4262018A (en) * 1977-12-23 1981-04-14 Research Corporation Cerium containing hypoglycemic agents
US4559223A (en) * 1983-05-20 1985-12-17 Daltex Medical Sciences, Inc. Silver sulfadiazine and/or zinc sulfadiazine-containing toothpaste or oral medicament
US20100187178A1 (en) * 2003-01-29 2010-07-29 Molycorp Minerals, Llc Process for removing and sequestering contaminants from aqueous streams
US6863825B2 (en) * 2003-01-29 2005-03-08 Union Oil Company Of California Process for removing arsenic from aqueous streams
US8066874B2 (en) * 2006-12-28 2011-11-29 Molycorp Minerals, Llc Apparatus for treating a flow of an aqueous solution containing arsenic
US8252087B2 (en) * 2007-10-31 2012-08-28 Molycorp Minerals, Llc Process and apparatus for treating a gas containing a contaminant
US8349764B2 (en) 2007-10-31 2013-01-08 Molycorp Minerals, Llc Composition for treating a fluid
US20090107919A1 (en) * 2007-10-31 2009-04-30 Chevron U.S.A. Inc. Apparatus and process for treating an aqueous solution containing chemical contaminants
US20090107925A1 (en) * 2007-10-31 2009-04-30 Chevron U.S.A. Inc. Apparatus and process for treating an aqueous solution containing biological contaminants
TW201038510A (en) * 2009-03-16 2010-11-01 Molycorp Minerals Llc Porous and durable ceramic filter monolith coated with a rare earth for removing contaminates from water
AR076275A1 (es) * 2009-04-09 2011-06-01 Molycorp Minerals Llc Uso de una tierra rara para la remocion de antimonio y bismuto
WO2011057281A1 (fr) * 2009-11-09 2011-05-12 Molycorp Minerals Llc Elimination de colorants au moyen de terres rares
US9233863B2 (en) 2011-04-13 2016-01-12 Molycorp Minerals, Llc Rare earth removal of hydrated and hydroxyl species
US10046079B2 (en) 2013-03-15 2018-08-14 Materials Modification Inc. Clay composites and their applications
US9975787B2 (en) 2014-03-07 2018-05-22 Secure Natural Resources Llc Removal of arsenic from aqueous streams with cerium (IV) oxide compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410793A (en) * 1940-03-01 1946-11-05 American Cyanamid Co Sulfonamido pyrimidines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3761590A (en) * 1970-05-18 1973-09-25 Research Corp Silver sulfadiazine used in the treatment of burns

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410793A (en) * 1940-03-01 1946-11-05 American Cyanamid Co Sulfonamido pyrimidines

Also Published As

Publication number Publication date
IL52483A0 (en) 1977-10-31
FR2358398B1 (fr) 1980-07-04
AU2663077A (en) 1979-01-04
US4078058A (en) 1978-03-07
AU512668B2 (en) 1980-10-23
LU77752A1 (fr) 1977-10-14
CA1071204A (fr) 1980-02-05
JPS5338615A (en) 1978-04-08
DE2731648A1 (de) 1978-01-19
ES460664A1 (es) 1978-12-01
JPS5527057B2 (fr) 1980-07-17
ZA774175B (en) 1978-05-30
IN146083B (fr) 1979-02-17
BE856751A (fr) 1978-01-12
GB1553322A (en) 1979-09-26
SE7708123L (sv) 1978-01-14
NL7707555A (nl) 1978-01-17

Similar Documents

Publication Publication Date Title
FR2358398A1 (fr) Medicament a base du sel cereux de la sulfadiazine
FR2372804A1 (fr) Derives d'amino-acides, en tant qu'agents anti-hypertension
FR2356424A1 (fr) Compositions pharmaceutiques a base d'acide phophono-formique utiles pour lutter contre les infections virales
FR2369241A2 (fr) Nouvelles substances a action physiologique deriv
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
FR2361892A1 (fr) Esters et amides des acides pyrimido(4,5-b)quinolein-4(3h)-one-2-carboxyliques, en tant qu'agents anti-ulceres
FR2428042A1 (fr) Procede de preparation d'analogues de cephalosporine et nouveaux produits ainsi obtenus, a activite antimicrobienne
FR2365567A1 (fr) Nouvelles piperazinylpyridines utiles comme medicaments
FR2377203A1 (fr) Melange stable a la conservation donnant par dissolution dans l'eau une solution a haute activite antimicrobienne
ES419560A1 (es) Procedimiento para la preparacion de n - (1'alcoxicarbonil-etil)-n-halocetil-2,6-dialquilanilinas.
MA47082B1 (fr) Amides aromatiques d'acide carboxylique en tant qu'antagonistes des recepteurs bradykinin b1
FR2374903A1 (fr) Nouvelle association utilisable en medecine veterinaire
FR2379508A1 (fr) Derive de benzalconium a action desinfectante et compositions pharmaceutiques renfermant ce compose
FR2374288A1 (fr) Nouvelles interphenylenes-11,12-secoprostaglandines utiles comme medicaments
FR2367737A1 (fr) Polypeptide, son procede de preparation et medicament le contenant
BE1002427A3 (fr) Nouvel acide piperazinecarboxylique, sa preparation et son utilisation comme medicament.
GB1309679A (en) Substituted sulphonanilides
FR2355852A1 (fr) Aminoglycosides, leur utilisation comme agents antibacteriens et leur preparation
US2594350A (en) Beta-diethylaminoethyl 3-phenyl-2-hydroxybenzoate mandelate
FR2378741A1 (fr) Acides garyl goxo isovaleriques doues de proprietes antiphlogistiques et antalgiques
US2606903A (en) Ascorbic acid addition compound of sulfathiazole
OA04690A (fr) Procédés de préparation de dérivés d'acide alkyl inférieur - 2 ou 3 -cephem-4-carboxylique, nouveaux produits ainsi obtenus et leur utilisation comme produits à activité antimicrobienne.
FR2371428A1 (fr) Stereo-isomeres du 1-(1'-benzyl-2'-pyrryl)-2-dibutyl sec.-amino-ethanol a activite analgesique et compositions pharmaceutiques qui les contiennent
FR2412534A1 (fr) Preparation de derives de 1-hydroxyaporphines
FR2380778A1 (fr) Compositions pharmaceutiques contenant des acides oxaniliques substitues ou leurs esters

Legal Events

Date Code Title Description
ST Notification of lapse